Published in Am J Respir Crit Care Med on November 01, 2000
Risk of tuberculin conversion among healthcare workers and the adoption of preventive measures. Occup Environ Med (2006) 1.08
Health and access to care for undocumented migrants living in the European Union: a scoping review. Health Policy Plan (2013) 1.04
Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study. BMC Infect Dis (2009) 0.87
Initiation and completion rates for latent tuberculosis infection treatment: a systematic review. BMC Infect Dis (2016) 0.84
Impact of immigration and HIV infection on tuberculosis incidence in an area of low tuberculosis prevalence. Epidemiol Infect (2006) 0.81
Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review. BMC Infect Dis (2016) 0.79
Stigma and Therapy Completion for Latent Tuberculosis among Haitian-origin Patients. Fla Public Health Rev (2010) 0.77
A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries. BMC Health Serv Res (2015) 0.77
Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients. BMC Res Notes (2013) 0.75
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (1998) 10.78
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA (2000) 8.42
Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ (1994) 6.11
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis (1998) 5.51
Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis (1997) 4.02
HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis (1992) 3.95
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J (2007) 3.67
Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis (2001) 3.51
Public health. Responding to market failures in tuberculosis control. Science (2001) 3.12
Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J (2007) 2.46
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab (2000) 2.43
Rhodococcus equi infection in HIV-infected patients. AIDS (1996) 2.32
Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA (1995) 2.08
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
Tuberculosis control in Europe and international migration. Eur Respir J (1994) 2.07
Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. Int J Tuberc Lung Dis (1999) 1.90
Predictors of atrial fibrillation after conventional and beating heart coronary surgery: A prospective, randomized study. Circulation (2000) 1.90
The impact of climate and traffic-related NO2 on the prevalence of asthma and allergic rhinitis in Italy. Clin Exp Allergy (2002) 1.87
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis (2002) 1.86
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis (2001) 1.84
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis (1994) 1.71
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 1.70
Predicting tuberculosis treatment outcome in a low-incidence area. Int J Tuberc Lung Dis (2008) 1.66
Are asthma-like symptoms due to bronchial or extrathoracic airway dysfunction? Lancet (1995) 1.63
Myocardial metabolic changes during pediatric cardiac surgery: a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg (2004) 1.61
Hyperresponsiveness of the extrathoracic airway in patients with captopril-induced cough. Chest (1990) 1.60
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest (2001) 1.59
Neurocysticercosis in an Italian traveler to Latin America. Am J Trop Med Hyg (1999) 1.53
Revelation of a novel CLN5 mutation in early juvenile neuronal ceroid lipofuscinosis. Neuropediatrics (2007) 1.53
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS (2000) 1.52
Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. Endocrine (2012) 1.50
Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS (1995) 1.48
The use of telemedicine for real-time video consultation between trauma center and community hospital in a rural setting improves early trauma care: preliminary results. J Trauma (2001) 1.46
Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr (2000) 1.46
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J (2011) 1.44
An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma. Eur Respir J (1998) 1.43
Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. Eur Respir J (1999) 1.42
A simple scoring system to assess risk of hematological side effects in zidovudine recipients. AIDS (1991) 1.38
Nonresponse bias in EC Respiratory Health Survey in Italy. Eur Respir J (1994) 1.37
L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology (2004) 1.36
SQUID-based microwave cavity search for dark-matter axions. Phys Rev Lett (2010) 1.36
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice. Am J Respir Crit Care Med (1994) 1.35
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. Ann Trop Med Parasitol (1994) 1.34
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts. Infection (2009) 1.33
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice. Am J Respir Crit Care Med (1998) 1.30
Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet (2001) 1.30
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother (2008) 1.26
Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy (2008) 1.26
Validation of the surveillance system for new cases of tuberculosis in a province of northern Italy. Varese Tuberculosis Study Group. Eur Respir J (1995) 1.25
Epidemiological features and case management practices of imported malaria in northern Italy 1991-1995. Trop Med Int Health (1999) 1.22
Undetected burden of tuberculosis in a low-prevalence area. Int J Tuberc Lung Dis (2006) 1.22
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy. Eur Respir J (2004) 1.21
Off-pump coronary artery bypass surgery for critical left main stem disease: safety, efficacy and outcome. Eur J Cardiothorac Surg (2001) 1.21
Improving the TB case management: The International Standards for Tuberculosis Care. Eur Respir J (2006) 1.19
Malaric placentas. A quantitative study and clinico-pathological correlations. Pathol Res Pract (1996) 1.19
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? Int J Tuberc Lung Dis (2001) 1.18
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis (2000) 1.18
Malaria in migrants. Parassitologia (1999) 1.17
Drug resistant tuberculosis among the homeless in New York City. N Y State J Med (1990) 1.17
Sexually transmitted diseases in travelers. Clin Infect Dis (2001) 1.15
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Clin Microbiol Infect (2011) 1.15
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment. J Infect Dis (2000) 1.14
Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free Radic Biol Med (2000) 1.14
Management of multidrug-resistant tuberculosis in Italy. Int J Tuberc Lung Dis (2005) 1.13
Dynamics and control of the global tuberculosis epidemic. Curr Opin Pulm Med (2000) 1.10
The placenta and malaria. Ann Trop Med Parasitol (1997) 1.10
Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia. Eur J Cardiothorac Surg (2002) 1.10
Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circulation (2001) 1.10
Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes (2000) 1.10
Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother (1998) 1.09
Implementation of tuberculosis infection control measures at HIV care and treatment sites in sub-Saharan Africa. Int J Tuberc Lung Dis (2012) 1.09
Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. Int J Tuberc Lung Dis (1997) 1.08
Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother (2002) 1.08
Soil transmitted helminth (STH) infections in an indigenous community in Ortigueira, Paraná, Brazil and relationship with its nutritional status. Parassitologia (2002) 1.07
Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues. Anticancer Res (2005) 1.07
Costs and benefits of improving tuberculosis control: the case of Thailand. Soc Sci Med (1997) 1.06
The role of climate on the geographic variability of asthma, allergic rhinitis and respiratory symptoms: results from the Italian study of asthma in young adults. Allergy (2004) 1.06
Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture. Neuropathol Appl Neurobiol (2013) 1.05
DOTS expansion: will we reach the 2005 targets? Int J Tuberc Lung Dis (2004) 1.05
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab (1996) 1.05
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors. J Med Virol (2006) 1.04
Beating versus arrested heart revascularization: evaluation of myocardial function in a prospective randomized study. Eur J Cardiothorac Surg (1999) 1.03
Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAl project. Dement Geriatr Cogn Disord (2007) 1.03
A new questionnaire for the repeat of the first stage of the European Community Respiratory Health Survey: a pilot study. Eur Respir J (1999) 1.03
Cardiopulmonary bypass-induced myocardial reoxygenation injury in pediatric patients with cyanosis. J Thorac Cardiovasc Surg (2002) 1.03
Genotyping analyses of tuberculosis transmission among immigrant residents in Italy. Clin Microbiol Infect (2009) 1.03
Asymptomatic carriage of verocytotoxin-producing Escherichia coli O157 in farm workers in Northern Italy. Epidemiol Infect (2004) 1.02
Prevalence of respiratory symptoms in migrant children to Italy: the results of SIDRIA-2 study. Allergy (2007) 1.02